Argenx
ARGX
#558
Rank
$33.85 B
Marketcap
$555.11
Share price
-5.92%
Change (1 day)
43.43%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Earnings for Argenx (ARGX)

Earnings in 2024 (TTM): $85.18 Million USD

According to Argenx 's latest financial reports the company's current earnings are $2.19 Billion USD. , an increase over its 2023 earnings that were of -$0.31 Billion USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Argenx from 2013 to 2024

Annual earnings

Year Earnings Change
2024 $85.18 M-127.97%
2023 -$0.31 Billion-58.25%
2022 -$0.73 Billion
2019 -$0.2 Billion124.95%
2018 -$88.5 Million132.04%
2017 -$38.14 Million54.86%
2016 -$24.63 Million33%
2015 -$18.52 Million13.63%
2014 -$16.3 Million46.25%
2013 -$11.15 Million